Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know

Area of Science:

• Neuroimmunology
• Microbiome Research
• Environmental Health

Background:

• Rising incidence of multiple sclerosis (MS) suggests environmental influences.
• The gut-brain axis is a critical communication pathway between the central nervous system and gut microbiota.
• Understanding these connections is vital for MS pathogenesis and treatment.

Purpose of the Study:

• To review current research on the gut-brain axis in relation to multiple sclerosis.
• To summarize findings on the impact of disease-modifying treatments on the gut microbiome of MS patients.

Main Methods:

• Literature review of recent studies on MS, gut-brain axis, and gut microbiome.
• Analysis of clinical data assessing treatment effects on MS patient gut microbiota.

Main Results:

• The gut-brain axis plays a significant role in mediating MS.
• Disease-modifying treatments can alter the gut microbiome composition in MS patients.

Conclusions:

• Environmental factors and the gut microbiome are increasingly recognized as important in MS.
• Further research into the gut-brain axis and microbiome modulation holds therapeutic potential for MS.